Paclitaxel-Loaded Nanosponges Inhibit Growth and Angiogenesis in Melanoma Cell Models.

angiogenesis melanoma mouse model nanosponges paclitaxel tumor growth

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2019
Historique:
received: 08 02 2019
accepted: 17 06 2019
entrez: 30 7 2019
pubmed: 30 7 2019
medline: 30 7 2019
Statut: epublish

Résumé

This study investigated the effects of free paclitaxel (PTX) and PTX-loaded in pyromellitic nanosponges (PTX-PNS) in reducing

Identifiants

pubmed: 31354491
doi: 10.3389/fphar.2019.00776
pmc: PMC6639435
doi:

Types de publication

Journal Article

Langues

eng

Pagination

776

Références

Mol Biol Cell. 2000 Sep;11(9):2999-3012
pubmed: 10982396
Clin Cancer Res. 2002 Apr;8(4):1182-8
pubmed: 11948131
Nature. 2002 Jun 27;417(6892):949-54
pubmed: 12068308
J Biomed Mater Res A. 2003 May 1;65(2):209-14
pubmed: 12734814
Melanoma Res. 2005 Oct;15(5):453-9
pubmed: 16179874
Oncology (Williston Park). 2009 May;23(6):488-96
pubmed: 19544689
Cell Immunol. 2010;263(1):79-87
pubmed: 20346445
Drug Deliv. 2010 Aug;17(6):419-25
pubmed: 20429848
N Engl J Med. 2010 Aug 26;363(9):809-19
pubmed: 20818844
Curr Drug Deliv. 2011 Mar;8(2):194-202
pubmed: 21235471
Methods Mol Biol. 2011;716:157-68
pubmed: 21318905
Food Chem Toxicol. 2012 Sep;50(9):3181-9
pubmed: 22683487
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Mol Imaging. 2012 Nov-Dec;11(6):487-98
pubmed: 23084249
Beilstein J Org Chem. 2012;8:2091-9
pubmed: 23243470
PLoS One. 2013 Sep 30;8(9):e75193
pubmed: 24098684
J Immunol. 2014 May 15;192(10):4921-31
pubmed: 24729612
Expert Opin Drug Deliv. 2014 Jun;11(6):931-41
pubmed: 24811423
Assay Drug Dev Technol. 2014 May;12(4):207-18
pubmed: 24831787
Chemistry. 2015 Jan 7;21(2):715-25
pubmed: 25388328
N Engl J Med. 2015 Jan 1;372(1):30-9
pubmed: 25399551
J Pharm Sci. 2015 May;104(5):1856-63
pubmed: 25754724
Curr Pharm Biotechnol. 2016;17(3):248-55
pubmed: 26517333
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016 Jul;8(4):579-601
pubmed: 26800431
Chin J Cancer. 2017 Jan 13;36(1):10
pubmed: 28086948
Adv Drug Deliv Rev. 2017 Dec 1;122:20-30
pubmed: 28257998
Ann Oncol. 2017 Jul 1;28(7):1631-1639
pubmed: 28475671
Nano Lett. 2017 Oct 11;17(10):6366-6375
pubmed: 28858519
Free Radic Biol Med. 2018 Feb 1;115:447-457
pubmed: 29248722
Biomed Pharmacother. 2018 Jan;97:1521-1537
pubmed: 29793315
ACS Appl Mater Interfaces. 2018 Oct 10;10(40):33976-33985
pubmed: 30203956
Drug Dev Ind Pharm. 2019 Mar;45(3):365-378
pubmed: 30394795

Auteurs

Nausicaa Clemente (N)

Department of Health Sciences and Interdisciplinary Research Center of Autoimmune Diseases (IRCAD), UPO, Novara, Italy.

Monica Argenziano (M)

Dipartimento di Scienza e Tecnologia del Farmaco, University of Torino, Torino, Italy.

Casimiro Luca Gigliotti (CL)

Department of Health Sciences and Interdisciplinary Research Center of Autoimmune Diseases (IRCAD), UPO, Novara, Italy.

Benedetta Ferrara (B)

Dipartimento di Scienza e Tecnologia del Farmaco, University of Torino, Torino, Italy.

Elena Boggio (E)

Department of Health Sciences and Interdisciplinary Research Center of Autoimmune Diseases (IRCAD), UPO, Novara, Italy.

Annalisa Chiocchetti (A)

Department of Health Sciences and Interdisciplinary Research Center of Autoimmune Diseases (IRCAD), UPO, Novara, Italy.

Fabrizio Caldera (F)

Department of Chemistry, University of Torino, Torino, Italy.

Francesco Trotta (F)

Department of Chemistry, University of Torino, Torino, Italy.

Elisa Benetti (E)

Dipartimento di Scienza e Tecnologia del Farmaco, University of Torino, Torino, Italy.

Laura Annaratone (L)

Department of Medical Sciences, University of Torino, Torino, Italy.

Simone Ribero (S)

Department of Medical Sciences, University of Torino, Torino, Italy.

Stefania Pizzimenti (S)

Department of Clinical and Biological Sciences, University of Torino, Torino, Italy.

Giuseppina Barrera (G)

Department of Clinical and Biological Sciences, University of Torino, Torino, Italy.

Umberto Dianzani (U)

Department of Health Sciences and Interdisciplinary Research Center of Autoimmune Diseases (IRCAD), UPO, Novara, Italy.

Roberta Cavalli (R)

Dipartimento di Scienza e Tecnologia del Farmaco, University of Torino, Torino, Italy.

Chiara Dianzani (C)

Dipartimento di Scienza e Tecnologia del Farmaco, University of Torino, Torino, Italy.

Classifications MeSH